TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma

MLA

Yue Peng, et al. “TIGIT/CD47 Dual High Expression Predicts Prognosis and Is Associated with Immunotherapy Response in Lung Squamous Cell Carcinoma.” Thoracic Cancer, vol. 13, no. 14, July 2022, pp. 2014–23. EBSCOhost, https://doi.org/10.1111/1759-7714.14478.

APA

Yue Peng, Bin Qiu, Fengwei Tan, Jiachen Xu, Fenglong Bie, Huayu He, Lei Liu, He Tian, Guangyu Bai, Bolun Zhou, Yuan Li, Qilin Huai, Zhenlin Yang, & Shugeng Gao. (2022). TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma. Thoracic Cancer, 13(14), 2014–2023. https://doi.org/10.1111/1759-7714.14478

Chicago

Yue Peng, Bin Qiu, Fengwei Tan, Jiachen Xu, Fenglong Bie, Huayu He, Lei Liu, et al. 2022. “TIGIT/CD47 Dual High Expression Predicts Prognosis and Is Associated with Immunotherapy Response in Lung Squamous Cell Carcinoma.” Thoracic Cancer 13 (14): 2014–23. doi:10.1111/1759-7714.14478.